Joseph Volavka, far left, stood alongside Dolan Family Health Center and Pink Aid members to celebrate the $25,000 grant. Photo from Dolan Family Health Center
Woman can receive free mammograms, sonograms and breast biopsies at Huntington Hospital’s Women’s Center and the Charles and Helen Reichert Imaging Center at Huntington with the help of a new grant.
On Friday, Aug. 7, Pink Aid, an organization that aims to help women receive and survive breast cancer treatment, gave the Dolan Family Health Center a one-year, $25,000 grant.
According to Joseph Volavka, senior administrative director of the Dolan Family Health Center, around 23 percent of the center’s patients pay out of pocket for their regular appointment. The purpose of the grant is to encourage women who may not have health insurance to receive free breast screenings, which can be costly. Most patients usually have enough money to pay for their regular appointments, so the grant gives more women the opportunity to get additional health care than they would otherwise receive due to financial limitations.
“We are very grateful for this grant, which will help so many women to get the medical care that they need, and it will also help their families.” Kathy Giffuni, RN, nurse manager of the Dolan Family Health Center, said in a press release.
People should go through several bottles of sunscreen in one season. Using an ounce of sunscreen is ideal, as companies measure the SPF of a sunscreen by applying that amount of sunscreen to the body. Photo by Giselle Barkley
A little dab here and a little dab there. That’s usually how people apply sunscreen to their skin, according to Dr. Michael Dannenberg of Dermatology Associates of Huntington, chief of dermatology at Huntington Hospital. But with around one in five people developing skin cancer on their scalp, a dab of sunscreen isn’t enough.
Skin cancer is one of the most prevalent cancers in America, and cases for scalp cancer have increased in the past several years. While those who don’t have hair may be more prone to getting scalp cancer in comparison to those with hair, anyone can develop any form of skin cancer on this area of their body.
Squamous cell and basal cell carcinoma are common for those who are frequently exposed to the sun and those who are losing hair. Melanoma can also develop on the scalp. In 1935, one in 1,500 people developed melanoma, but the rate has since increased. Now, one in 50 people have a lifetime risk of developing melanoma.
According to Dr. Tara Huston, a surgeon in the Melanoma Management Team for Stony Brook Medicine, there will be 74,000 new cases this year of melanoma in the United States alone. Huston also said that this form of skin cancer usually requires a surgeon’s attention, as it calls for “a larger excision margin than either basal or squamous cell skin cancer.”
Huston and her team help patients with various forms of skin cancer. While dermatologists treat skin cancers like melanoma if caught early, people with more advanced stages of skin cancer may need surgery and additional treatment to recover. A patient’s lymph nodes are also examined. Lymph nodes are responsible for the drainage of certain parts of the skin. Doctors can further repair issues found from examining the nodes associated with the cancer in that area.
Sunburns, above, and increased sun exposure increase an individual’s risk of getting skin cancer like Melanoma, which accounts for four percent of cases, but 75 percent of skin cancer-related deaths according to Dr. Huston. Photo from Alexandra Zendrian
Although skin cancer of the scalp is not difficult to detect, Dr. Dannenberg says it can be missed because it is on the head. Lesions can vary based on the form of skin cancer on the scalp. Yet, it is easy to detect, especially when people receive frequent haircuts. According to Dannenberg, his office receives countless referrals from barbers and hairstylists who may find a cancerous lesion on their client’s heads.
Huston agreed with Dannenberg regarding the role of barbers and hairstylists, as a number of skin cancer lesions are identified by these professionals.
Squamous cell carcinoma appears in dull, red, rough and scaly lesions, while basal cell carcinoma appears as raised, pink and wax-like bumps that can bleed. Melanoma on the scalp appears as it would on any other part of the body — irregularly shaped, dark-colored lesions.
While sunscreen is more often associated with skin protection, dermatologists like Dannenberg also recommend protective clothing and hats. Cloth hats allow the wearer’s head to breathe while protecting the scalp. Hats with a three and a half inch or more rim offer the best protection, as they cover the head while protecting the ears and other parts of the face or neck. While people can also use straw hats, the hats should be densely woven and not allow sun to penetrate. Hats as well as sunscreen and protective clothing should be used together to provide people with the best form of sun protection.
“Nobody is completely compulsive about putting on that hat every moment they walk out the door,” Dannenberg said. “Likewise, even for people [who] are using sunscreens, people tend not to use enough of it and they don’t reapply it as often as necessary.”
One ounce of sunscreen might be hard to hold without dripping down the side of someone’s hand, but it is the amount of sunscreen people should use on their entire body. Dannenberg also says that sunscreens usually last for about three hours before people need to reapply.
Since few people follow the directions when applying sunscreen, Dannenberg as well as the American Academy of Dermatology recommend people use sunscreens with at least SPF 30. Using sunscreens with higher SPF counts means that people can under apply and still get some degree of sun and ultraviolet radiation protection.
Huston said individuals who don’t want to wear sunscreen or those with a history of tanning should seek a dermatologist and schedule appointments at least once a year to conduct a full body skin examination.
According to Huston, operating on areas of the head like the ears, nose, eyelids, lips and scalp is difficult because of the surrounding tissue.
“Reconstruction of a 2 cm defect on the nose may require multiple stages/surgeries in order to optimize the aesthetic result,” Huston said in an e-mail interview.
While some patients need skin grafts upon the removal of a cancerous lesion, Huston said, “incisions on the scalp can lead to alopecia, or hair loss along the incision line, if it stretches, and can be very upsetting to patients.”
Both Huston and Dannenberg emphasized the importance of protecting the skin and skin cancer education. Dannenberg hopes that the rates of skin cancer will decrease if people are more consistent about protecting their skin with protective attire, sunscreen and hats.
“We’ve been talking to people for years about wearing hats…telling them that as fashion always seems to follow need, that these hats are going to be coming in style,” Dannenberg said. “We’re hoping that over the next 10 or 15 years, we’ll be able to get a drop in the incidences of skin cancer.”
Longer days are here again, and you can feel the jubilance of people coming out of hibernation after a long, hard winter. Summer weather will be here before you know it, and millions will be heading to the beaches.
What could possibly be wrong with this picture? With all these benefits, you need to be cognizant of cutaneous (skin) melanoma. It is small in frequency, compared to basal cell and squamous cell carcinomas, responsible for only about 5 percent of skin cancers; however, it is much more deadly.
STATISTICS
Unfortunately, melanoma is on the rise. Over the last 40 years from 1970 to 2009, its incidence has increased by 800 percent in young women and by 400 percent in young men (1). These were patients diagnosed for the first time between 18 and 39 years old. Overall, the risk is greater in men, with 1 in 37 afflicted by this disease in his lifetime. The rate among women is 1 in 56. It is predicted that in 2014, there will have been over 76,000 cases, with over 12 percent resulting in death (2).
Melanoma risk involves genetic and environmental factors. These include sun exposure that is intense but intermittent, tanning beds, UVA radiation used for the treatment of psoriasis, the number of nevi (moles), Parkinson’s disease, prostate cancer, family history and personal history. Many of these risk factors are modifiable (3).
PRESENTATION
Fortunately, melanoma is mostly preventable. What should you look for to detect melanoma at its earliest stages? In medicine, we use the mnemonic “ABCDE” to recall key factors to look for when examining moles. This stands for asymmetric borders (change in shape); border irregularities; color change; diameter increase (size change); and evolution or enlargement of diameter, color or symptoms, such as inflammation, bleeding and crustiness (4). Asymmetry, color and diameter are most important, according to guidelines developed in England (5).
It is important to look over your skin completely, not just partially, and have a dermatologist screen for potential melanoma. Screening skin for melanomas has shown a six-times greater chance of detecting them. Skin areas exposed to the sun have the highest probability of developing the disease. Men are more likely to have melanoma tumors on the back, while women are more likely to have melanoma on the lower legs, but they can develop anywhere (6).
In addition, most important to the physician, especially the dermatologist, is the thickness of melanoma. This may determine its probability to metastasize. In a recent retrospective (backward-looking) study, the results suggest that melanoma of >0.75 mm needs to not only be excised, or removed, but also have the sentinel lymph node (the closest node) biopsied to determine risk of metastases (7). A positive sentinel node biopsy occurred in 6.23 percent of those with thickness >0.75 mm, which was significantly greater than in those with thinner melanomas. When the sentinel node biopsy is positive, there is a greater than twofold increase in the risk of metastases. On the plus side, having a negative sentinel node helps relieve the stress and anxiety that the melanoma tumor has spread.
PREVENTION
The two most valuable types of prevention are clothing and sunscreen. Let’s look at these in more detail.
Clothing
Clothing can play a key role in reducing melanoma risk. The rating system for clothing protection is the ultraviolet protection factor (UPF). The Skin Cancer Foundation provides a list of which laundry additives, clothing and cosmetics protect against the sun (8). Clothing that has a UPF rating between 15 and 24 is considered good, 25 and 39 is very good, and 40 and 50 is excellent. The ratings assess tightness of weave, color (the darker the better), type of yarn, finishing, response to moisture, stretch and condition. The most important of these is the weave tightness (9).
Interestingly, the New York Times wrote about how major companies are producing sun protective clothing lines that are fashionable and lighter in weight. The article is entitled “Fashionable Options Reshape Sun-Protective Clothing,” published on July 17, 2013 (10).
Sunscreen
We have always known that sunscreen is valuable. But just how effective is it? In an Australian prospective (forward-looking) study, those who were instructed to use sun protective factor (SPF) 16 sunscreen lotion on a daily basis had significantly fewer incidences of melanoma compared to the control group members, who used their own sunscreen and were allowed to apply it at their discretion (11). The number of melanomas in the treatment group was half that of the control group’s over a 10-year period. But even more significant was a 73 percent reduction in the risk of advanced-stage melanoma in the treatment group. Daily application of sunscreen was critical.
The recommendation after this study and others like it is that an SPF of 15 should be used daily by those who are consistently exposed to the sun and/or are at high risk for melanoma according to the American Academy of Dermatology (12). The amount used per application should be about one ounce. However, since people don’t use as much sunscreen as they should, the academy recommends an SPF of 30 or higher. Note that SPF 30 is not double the protection of SPF 15. The UVB protection of SPFs 15, 30 and 50 are 93, 97 and 98 percent, respectively.
The problem is that SPF is a number that registers mostly the blocking of UVB but not so much the blocking of UVA1 or UVA2 rays. However, 95 percent of the sun’s rays that reach sea level are UVA. So what to do?
Sunscreens come in a variety of UV filters, which are either organic filters (chemical sunscreens) or inorganic filters (physical sunscreens). The FDA now requires broad-spectrum sunscreens pass a test showing they block both UVB and UVA radiation. Broad-spectrum sunscreens must be at least SPF 15 to decrease the risk of skin cancer and prevent premature skin aging caused by the sun. Anything over the level of SPF 50 should be referred to as 50+ (3).
The FDA also has done away with the term “waterproof.” Instead, sunscreens can be either water resistant or very water resistant, if they provide 40 and 80 minutes of protection, respectively. This means you should reapply sunscreen if you are out in the sun for more than 80 minutes, even with the most protective sunscreen (3). Look for sunscreens that have zinc oxide, avobenezene or titanium oxide; these are the only ones that provide UVA1 protection, in addition to UVA2 and UVB protection.
In conclusion, to reduce the risk of melanoma, proper clothing with tight weaving and/or sunscreen should be used. The best sunscreens are broad spectrum, as defined by the FDA, and should contain zinc oxide, avobenezene or titanium oxide to make sure the formulation not only blocks UVA2 but also UVA1 rays. It is best to reapply sunscreen every 40 to 80 minutes, depending on its rating. We can reduce the risk of melanoma occurrence significantly with these very simple steps.
REFERENCES:
(1) Mayo Clin Proc. 2012; 87(4): 328–334. (2) CA Cancer J Clin. 2014;64(1):9. (3) uptodate.com. (4) JAMA. 2004;292(22):2771. (5) Br J Dermatol. 1994;130(1):48. (6) Langley, RG et al. Clinical characteristics. In: Cutaneous melanoma, Quality Medical Publishing, Inc, St. Louis, 1998, p. 81. (7) J Clin Oncol. 201;31(35):4385-4386. (8) skincancer.org. (9) Photodermatol Photoimmunol Photomed. 2007;23(6):264. (10) nytimes.com. (11) J Clin Oncol. 2011;29(3):257. (12) aad.org.
Dr. Dunaief is a speaker, author and local lifestyle medicine physician focusing on the integration of medicine, nutrition, fitness and stress management. For further information, go to the website www.medicalcompassmd.com and/or consult your personal physician.
Journey benefits cancer research, education and treatment
Kevin Rooney is ready to take on a 150-mile bike ride for cancer research. Photo from CRI
This weekend’s 150-mile journey through Westchester, from Yonkers to Pound Ridge, isn’t Kevin Rooney’s first lengthy bike ride, but this one is definitely personal.
Rooney, 53, has so far raised more than $3,200 for the Cancer Research Institute’s inaugural New York Ride to Conquer Cancer, in which he is participating in honor of his parents, George and Mary, and his father-in-law, Clifford, all of whom died from cancer. The Mount Sinai resident is also riding in honor of his wife Lynn’s aunt and a close family friend who have battled the disease, which affects more than 1 million people in the United States every year, according to the American Cancer Society.
“I’m thinking about them and doing what I can do to make things better for them,” Rooney said.
The nonprofit Cancer Research Institute will use the funds for research, treatment and education.
An avid cycler for more than 20 years, the ride is far from Rooney’s first. But the father of two kids — Kathryn, 11, and Colin, 10 — has a busy schedule that leaves not as much time to race as he once did. In order to prepare for the June 6 to June 7 expedition, Rooney said he has been riding about three times a week. He typically gets up at 4 a.m. and works out for about an hour on a training bicycle, and tries to go out on weekends for a 50- to 60-mile ride.
“I just wanted to do something to the best of my athletic ability,” Rooney said.
Kevin Rooney with his wife, Lynn, and their children, Colin and Kathryn. Photo from CRI
He said cycling enables him to work through stress and acts as a meditation ritual.
Lynn Rooney said her husband’s motivation and commitment to the cause is “very encouraging,” and “something that I admire.”
Kevin Rooney was at first a little concerned about asking people to donate money, but as the donations started pouring in, he realized just how many people the disease affects.
“It touches people,” he said. “You find out how prevalent [the disease is].”
While his family won’t watch from the race sidelines, as Colin — an athlete like his dad — has a soccer match Rooney didn’t want him to miss, the father will have some guidance along the way. He said the pictures of those who inspired him are printed on his race number and will be tagging along for the ride.
For more information visit, www.ridetovictory.org.
An exterior view of the Stony Brook University Cancer Center. Photo from SBU
By L. Reuven Pasternak, MD
Thanks to major advances in cancer prevention, early detection and treatment, many patients are enjoying longer lives and maintaining their quality of life, as the number of cancer survivors grows.
Anyone living with a history of cancer — from the moment of diagnosis through the remainder of life — is a cancer survivor, according to the National Cancer Survivors Day Foundation. In the United States alone, there are more than 14 million cancer survivors. That’s cause for celebration, and for the past 10 years, that’s exactly what we’ve been doing at Stony Brook University Cancer Center at our annual National Cancer Survivors Day event.
Stony Brook’s 11th annual celebration will take place on Sunday, June 14, from 11 a.m. to 3 p.m., at the Cancer Center, and will feature a talk about the Cancer Survivorship Movement by inspirational speaker Doug Ulman. A three-time cancer survivor and a globally recognized cancer advocate, Ulman, with his family, founded the Ulman Cancer Fund for Young Adults. The nonprofit organization is dedicated to supporting, educating and connecting young adults who are affected by cancer. Ulman is also known for his work at LIVESTRONG and now as president and CEO of Pelotonia.
All cancer survivors are invited, whether they were treated at Stony Brook or not. In addition to Ulman’s talk, attendees can enjoy a variety of outdoor activities, musical entertainment and light refreshments. They can also participate in the very moving Parade of Survivors. To register, visit www.cancer.stonybrookmedicine.edu/registration or call 631-444-4000.
Cancer Center staff members actively partake in the day’s events and look forward to reconnecting with patients. It’s gratifying for them to see the strides these survivors have made throughout the years to lead normal and productive lives after a cancer diagnosis.
National Cancer Survivors Day is just one of a number of ways Stony Brook reaches out to the community. The Cancer Center has created many initiatives and programs to help make life a little easier for patients with cancer, including support groups, cancer prevention screenings and the School Intervention and Re-Entry Program for pediatric patients.
As a leading provider of cancer services in Suffolk County, Stony Brook is constructing a state-of-the-art Medical and Research Translation (MART) building that will focus on cancer research and advanced imaging and serve as the home of our new Cancer Center. Located on the Stony Brook Medicine campus, this 245,000-square-foot facility will allow scientists and physicians to work side by side to research and discover new cancer treatments and technology.
The MART will double Stony Brook’s capacity for outpatient cancer services and enhance all cancer care for Long Island and beyond. And once it is completed in 2016, we’ll have one more reason to celebrate life after a cancer diagnosis.
L. Reuven Pasternak, MD, is the CEO of Stony Brook University Hospital and vice president for health systems, Stony Brook Medicine.
Determined to help develop better treatments and, perhaps even a cure, Douglas Fearon, a medical doctor, decided to conduct research instead of turning to existing remedies. More than two decades later, Fearon joined Cold Spring Harbor Laboratory and is working on ways to help bodies afflicted with cancer heal themselves.
Fearon is focusing on the battle cancer wages with the T lymphocytes cells of human immune systems. Typically, these cells recognize threats to human health and destroy them. The pancreatic cancer cells he’s studying, however, have a protective mechanism that is almost like a shield. “The cancer is killing the T cells before the T cells can kill the cancer,” said Fearon.
The T cells have a complex signaling pathway on their surface that allows them to link up with other objects to determine whether these cells are friend or foe. In pancreatic cancer, Fearon has focused on a receptor that, when attached to the deadly disease, may disarm the T cell.
Researchers had already developed a small molecule that blocks the receptor on the T lymphocytes from linking up with this protein for another disease: the human immunodeficiency virus. When Fearon applied this molecule to a mouse model of pancreatic cancer, the therapy showed promise. “Within 24 hours, T cells were infiltrating the cancer cells,” he said. “Within 48 hours, the tumors had shrunk by 15 percent. This drug overcame the means by which cancer cells were escaping.”
This month, doctors at the University of Cambridge School of Clinical Medicine, where Fearon worked for 20 years, plan to begin Phase I human trials of this treatment for pancreatic cancer. Later this year, doctors at the Weill Cornell Medical College in New York City, where Fearon has a joint appointment, will begin a similar effort.
Scientists are encouraged by the early results from Fearon’s treatment. The Lustgarten Foundation named Fearon one of three inaugural “Distinguished Scholars” last year, awarding him $5 million for his research over the next five years.
The scientific advisory board at the Foundation “expects distinguished scholars to be on the leading edge of breakthrough therapies and understanding for this disease,” said David Tuveson, a professor and director of the Lustgarten Foundation Pancreatic Cancer Center Research Laboratory at CSHL.
During the early stage trials, doctors will increase the dosage to a level HIV patients had received during early experiments with the drug, called AMD 3100 or Plerixafor.
While Fearon is cautiously optimistic about this approach, he recognizes that there are many unknowns in developing this type of therapy. For starters, even if the treatment is effective, he doesn’t know whether the cancer may recur and, if it does, whether it might adapt some way to foil the immune system’s attempt to eradicate it.
Additionally, the receptor the doctors are blocking is required for many other functions in humans and mice. In mice, for example, the receptor on the T cell has a role in the developing nervous system and it also plays a part in a process called chemotaxis, which directs the migration of a cell.
“After giving this drug to HIV patients for 10 days, there were no long-term effects,” Fearon said. Researchers and doctors don’t “know for sure if you continued blocking this receptor what the long-term effects” would be.
Fearon and his wife Clare are renting a cottage in Lloyd Neck and have an apartment on the Upper East Side. Their daughter Elizabeth recently earned her Ph.D. in epidemiology in Cambridge, England while their son Tom, who is working toward a graduate degree in psychology, is interested in a career in counseling.
A native of Park Slope, Brooklyn who was the starting quarterback for Williams College in Massachusetts in his junior and senior years, Fearon feels it’s a “privilege to do something that may have a positive effect” on people’s lives.
Fearon is especially pleased to work at CSHL, where he said he can collaborate with colleagues who often immediately see the benefits of such a partnership. He has worked with Mikala Egeblad on intravital imaging, which is a type of microscope that allows him to look at living tissue. They are sharing the cost of buying a new instrument. Working with her “facilitated my ability to start up a project in my lab using a similar technique,” Fearon said.
Marissa Pastore and her mom, flanked by Disney characters. Photo from Katrina Kurczak
A 14-year-old Huntington Station girl who was recently diagnosed with a terminal illness got the wish of her life on Sunday when her favorite Disney characters came out to celebrate with her.
Marissa Pastore, who has been diagnosed with acute lymphoblastic leukemia (ALL) on April 20, was treated at the Cohen Children’s Center, but her fragile body was unable to handle the chemotherapy, according to a GoFundMe online fundraising account set up for the family. A few days later, Marissa returned home with her mom Risa, dad Domenick and two brothers Domenick and Ryan, to enjoy their final days together.
Marissa’s mom is an emergency department nurse at Huntington Hospital and her dad is a former Huntington Manor Fire Department chief and a fireman with the New York City Fire Department (FDNY), according to the account. Both are volunteers at the Huntington Manor Fire Department, and the account was set up so the family could “concentrate solely on loving Marissa.”
Marissa Pastore, 14, gets the surprise of a lifetime when Disney characters visit her. Photo from Katrina Kurczak
“Please help us support the Pastore family with any donation you can make which will go toward covering their living expenses while they take time off from work to celebrate Marissa’s life together.”
Not only did the account amass more than $55,000 by Wednesday, Marissa got a special surprise when Minnie Mouse, Mickey Mouse, Olaf and other characters from popular Disney movies greeted the 14-year-old Disney lover, thanks to the Make-A-Wish Foundation.
According to Katrina Kurczak, one of Marissa’s wish granters and assistant director of program services for Make-A-Wish, the nonprofit group and the family put together Marissa’s wish quickly. Family and community members contacted them Tuesday, April 28, and the group met with the family Wednesday. On Sunday, her wish came true.
“She was surprised and so happy, she couldn’t believe it,” Kurczak said. The characters rode in on fire trucks and greeted her.
The goal was to bring Disney to her, as Marissa is unable to travel due to her condition. Disney princesses Anna and Elsa from “Frozen” also made a special appearance and sang to the young girl.
“Her dad wanted to do something to make her smile,” Kurczak said.
Many volunteers came together to help make the day as special as possible. The Huntington Manor Fire Department, Cold Spring Harbor Fire Department and the FDNY also helped make Marissa’s wish come true.
To donate to the Pastore family, visit https://www.gofundme.com/sus6z8.
District Attorney Tom Spota holds up a jar Brittany Ozarowski used while falsely claiming she had cancer to solicit donations. File photo by Erika Karp
The Selden native who tricked Long Islanders into believing she had cancer and used donations to fund her heroin habit was sentenced to prison on Monday, after she violated the terms of a mandated drug treatment program, Suffolk County District Attorney Tom Spota said.
Brittany Ozarowski will spend one to three years behind bars after violating the terms of her drug treatment program. File photo
In December 2013, Brittany Ozarowski, 24, pleaded guilty to two counts of third-degree larceny; 10 counts of second-degree forgery; 10 counts of first-degree offering a false instrument for filing; one count of first-degree scheming to defraud; and one count of petit larceny. While the District Attorney’s office wanted Ozarowski to serve a maximum seven-year prison term, Judge John Iliou instead required her to enroll in the Suffolk County Judicial Diversion Program, an alternative sentencing program that includes drug addiction treatment instead of jail. Ozarowski’s sentence included one year of inpatient treatment, one year of outpatient treatment and a year of probation.
On Monday, Spota announced in a press release that she had violated the program’s terms and had thus been sentenced to one to three years in prison.
George Duncan, a Central Islip-based attorney representing Ozarowski, said while Ozarowski received “technical violations” that resulted in her prison sentence, her time spent in the treatment program “literally saved her life,” and she is aware and thankful for that.
Duncan and the DA’s office were unable to specify how exactly Ozarowski broke program rules, as doing so would violate the federal health care privacy laws.
Ozarowski was indicted on 24 counts and arrested in April 2013. According to the DA’s office, she claimed she had bone and brain cancer to solicit donations from customers at supermarkets and shops throughout Long Island, including in Terryville, Miller Place and Sayville. In addition, she got local businesses to hold fundraisers to benefit her alleged treatments and created a website with a PayPal account where people could donate. In reality, she was using the money to fuel her heroin addiction.
At the time of her arrest, investigators discovered more than $317 in a donation bucket. More than 20 locations with donation jars were later found and the DA’s office estimated Ozarowski defrauded more than $6,000.
The 2013 arrest wasn’t Ozarowski’s first. She has other heroin-related charges against her, including a driving under the influence charge from 2011, which is still pending. The DA’s office said the Newfield High School graduate tampered with letters from doctors to say she had cancer and submitted them to her attorney in order to postpone court hearings on the charges.
‘Short But Sweet,’ the butterfly bra created by Tammy Colletti in memory of her mother. Photo by Erin Dueñas
By Erin Dueñas
Covered in feathers, decorated in shells and bedazzled in rhinestones, the bras on display at the Wang Center at Stony Brook University last Thursday looked like they could have been part of the latest collection from an eccentric lingerie designer. The bras were actually created by members of the community, local businesses, cancer survivors and television personalities as part of Bodacious Bras for a Cure, a fundraising event to benefit women’s cancer programs at Stony Brook Cancer Center.
Dr. Michael Pearl says the services offered to cancer patients involved in the cancer center help to restore some control in their lives. Photo by Erin Duenas
Bodacious Bras was initiated by Linda Bily, director of Cancer Patient Advocacy and the Woman to Woman program at the center and inspired by a similar event called Creative Cups at Adelphi University. Bras were decorated and then put up for auction at the Stony Brook event. “It’s just a fun, different way of promoting awareness of all women’s cancers,” Bily said.
Twenty-two bras were auctioned off, raising $5,000 that will help fund women’s patient services at the Cancer Center.
According to Bily, each bra entry had to be created on a size 36C garment. Nothing perishable was permitted on the creations and the entire bra needed to be decorated. A brief summary accompanied each bra explaining the creator’s motivation. The “Mandala” bra, which fetched $250, created by local artist Jessica Randall, was made of shells and won the Best in Show prize. “I made this bra,” Randall’s summary read, “to honor women who have struggled with the debilitating disease of breast cancer.” “That Meatball Place” bra was created by the restaurant of the same name, located in Patchogue. Featuring bows and rhinestones and the restaurant’s logo, the bra fetched $500 at the auction. “Whichever [meatball] style suits you, we support them all, while always saving room for hope of a cure,” that summary read. Another bra called the “Hooter Holster” was created by Port Jefferson Station native Clinton Kelly, co-host of “The Chew.”
22 bras were featured at Bodacious Bras for a Cure bringing in $5000 to fund women’s cancer services. Photo by Erin Duenas
Tammy Colletti of Setauket made a bra called “Short But Sweet” dedicated to her mother Marion who passed away a year and a half ago. Using purple and teal feathers, the bra was made to look like a butterfly. A small vial containing a piece of paper that read “Cure Breast Cancer” rested in the center in between the feathers.
Colletti, who volunteers at the Cancer Center, said she was inspired to create a butterfly bra after watching her mother live out the remainder of her life in hospice care. “When they brought her in to hospice she was all wrapped up, and I told her it looked like she was in a cocoon,” Colletti said. When she passed away, Colletti imagined her mother shedding that cocoon and turning into a butterfly. “She was transformed into something beautiful, into something that I know is flying all around us.”
The Cancer Center provides a wide variety of support to ill patients to help them cope with a cancer diagnosis. In the Woman to Woman program, patients can get help with childcare, transportation to treatments, financial assistance to pay for costs associated with being ill and selecting wigs if needed.
Dr. Michael Pearl, professor of medicine and chief of the Division of Gynecologic Oncology, said that a cancer diagnosis has a huge impact not just on the woman affected but on her family as well. “In a lot of families, the woman acts as the glue that keeps everything together,” Pearl said. When a woman gets sick, often the day-to-day operations of family life get disrupted. That is when the Woman to Woman program can step in.
“We have volunteers that provide active support services,” Pearl said. Services could even include driving a patient’s children to sports or band practice. “Getting sick takes away your control. The program tries to restore some control and normalcy into their day-to-day lives.”
Bily said she was expecting Bodacious Bras to take a while to catch on, but she was happy with the positive response of the event. “It was a great night,” she said. “People who designed a bra are already thinking about what they will make next year.”
Patricia Thompson photo from Stony Brook University
By Daniel Dunaief
Patricia Thompson gets a call from her sister Kathy Hobson when people in San Angelo, Texas — where Thompson grew up and where her sister and brother live — when someone has cancer. They want to know what Thompson thinks of their treatment.
While Thompson is not a medical doctor, she has been working as a scientist to develop ways to discriminate high-risk patient populations from low-risk patients to limit “toxic treatments in low-risk individuals” and improve the efficacy of aggressive treatment in high risk-patients. The goal, she said, is to better treat patients based on the specific pathobiology of their disease.
Thompson, who came to Stony Brook University last October as a professor of pathology and associate director of Basic Research at the Cancer Center, is pleased with the support from the university.
“There’s a real convergence of factors, including a strong commitment from the leadership, the Simons Center and the university medical school faculty and staff at Stony Brook,” she said. “We all want to see the Stony Brook Cancer Center bring prestige to our community, attract the finest talent in cancer research and clinical care and attract innovators and job builders.”
Thompson said Cancer Center Director Yusuf Hannun, Medical School Research Dean Lina Obeid, Pathology Department Chairman Ken Shroyer, and Dean of the Medical School Ken Kaushansky have all led the charge.
Shroyer is pleased Thompson joined the effort. “Bringing her here was an incredible coup,” he said. She brings “real national prominence” and led one of the “most important clinical and translational research programs in breast and colorectal cancer.”
Thompson is committed to furthering her own research studies, while balancing between critical basic science discoveries and their clinical impact.
For some scientists, she wants to assist researchers as they move from the bench to the first human study. She helps them understand who needs to be involved to advance a potential diagnostic tool or novel treatment.
Still, she endorses the benefits of basic research. “Application is always an important long-term goal, but scientific exploration for new discovery is critical to advancements,” she said. Applied and basic research are “neither mutually exclusive approaches.”
Thompson studies colorectal and breast cancer because both have an inflammatory component and an immune element. She’s exploring what is shared between these two cancers as common targets for prevention and treatment.
Colon cancer provides a window that helps scientists and doctors understand the way cancer progresses.
“Our ability to study the premalignant to malignant progression in colorectal cancer has provided important basic knowledge of how cancers develop and taught us about how cells defend against tumorigenesis and how these systems fail,” she said.
Thompson went through some formative professional and personal experiences during graduate school that shaped her career. In the mid-1990s, she was studying an autoimmune disease in which she worked on an animal model with a neuroimmunologist.
“I wanted to know that all this work I was doing with animals was contributing to the disease in humans,” she said.
Around the same time, her father, Jim Thompson, who owned and operated Angelo Tool Company, learned he had stage IV colorectal cancer. He was diagnosed in 1995, before major advances in colorectal cancer treatment. Her father received compassionate care use of a new therapy, enabling him to live for three more years, considerably longer than his initial two-month prognosis. If he had been diagnosed five years later and received a platinum-based regimen, he would have “gained even more time,” she said.
Thompson said she and her family struggle with the fact that her father showed symptoms he kept to himself, largely out of fear. If his cancer had been detected earlier, she believes it is likely he could have been cured.
She suggests people not be “afraid of a cancer diagnosis” and recommends “routine screening” and consultation with a doctor if they show symptoms.
Thompson lives in Rocky Point with her husband, Michael Hogan, who is the vice president of life sciences at Applied DNA Sciences.
As for her work, Thompson believes her research might help physicians and their patients.
Her research aims to develop “diagnostic tests that help in prognosis” while identifying “patients that may achieve more benefit from aggressive chemotherapy,” she said.
Prev
